From Biomarker to Mechanism? F2-isoprostanes in Pulmonary Fibrosis

被引：5

作者：

Thatcher, Thomas H. ^{[1
]}

Peters-Golden, Marc ^{[2
]}

机构：

[1] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA

[2] Univ Michigan, Med Sch, Dept Internal Med, Ann Arbor, MI USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 206卷 / 05期

关键词：

THROMBOXANE A(2); RECEPTOR;

D O I：

10.1164/rccm.202205-0914ED

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：530 / 532

页数：4

共 50 条

[41] Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab′)2 [J].

Leavenworth, Jianmei W. ;

Schellack, Carola ;

Kim, Hye-Jung ;

Lu, Linrong ;

Spee, Pieter ;

Cantor, Harvey .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (06) :2562-2567

[42] E2F1 promotes cytokine mediated cell survival via a mechanism that is separable from its cell cycle regulatory effects [J].

Gala, S ;

Williamson, P .

IMMUNOLOGICAL INVESTIGATIONS, 2004, 33 (02) :173-191

[43] Exploring the efficacy and molecular mechanism of Danhong injection comprehensively in the treatment of idiopathic pulmonary fibrosis by combining meta-analysis, network pharmacology, and molecular docking methods [J].

Wu, Xiaozheng ;

Li, Wen ;

Luo, Zhenliang ;

Chen, Yunzhi .

MEDICINE, 2024, 103 (19) :E38133

[44] Lung Fibroblasts from Patients with Idiopathic Pulmonary Fibrosis Exhibit Genome-Wide Differences in DNA Methylation Compared to Fibroblasts from Nonfibrotic Lung [J].

Huang, Steven K. ;

Scruggs, Anne M. ;

McEachin, Richard C. ;

White, Eric S. ;

Peters-Golden, Marc .

PLOS ONE, 2014, 9 (09)

[45] Pulmonary delivery of a recombinant RAGE antagonist peptide derived from high-mobility group box-1 in a bleomycin-induced pulmonary fibrosis animal model [J].

Piao, Chunxian ;

Zhuang, Chuanyu ;

Ko, Min Kyung ;

Hwang, Do Won ;

Lee, Minhyung .

JOURNAL OF DRUG TARGETING, 2022, 30 (07) :792-799

[46] Evaluation of cationic channel TRPV2 as a novel biomarker and therapeutic target in Leukemia-Implications concerning the resolution of pulmonary inflammation [J].

Siveen, Kodappully S. ;

Prabhu, Kirti S. ;

Parray, Aeijaz S. ;

Merhi, Maysaloun ;

Arredouani, Abdelilah ;

Chikri, Mohamed ;

Uddin, Shahab ;

Dermime, Said ;

Mohammad, Ramzi M. ;

Steinhoff, Martin ;

Janahi, Ibrahim A. ;

Azizi, Fouad .

SCIENTIFIC REPORTS, 2019, 9 (1)

[47] Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Wen-Yu-Jin against Pulmonary Fibrosis in a Mouse Model [J].

Wang, Lu ;

Zhu, Wenxiang ;

Sun, Rui ;

Liu, Jing ;

Ma, Qihong ;

Zhang, Binbin ;

Shi, Yuanyuan .

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022

[48] Preventive Effect and Mechanism of Anthocyanins from Aronia Melanocarpa Elliot on Hepatic Fibrosis Through TGF-β/Smad Signaling Pathway [J].

Hao, Ruobing ;

Gao, Jun ;

Liu, Hongwei ;

Zhang, Chenjuan ;

Huang, Jinpeng ;

Fan, Jungang ;

Wei, Jie .

CELL BIOCHEMISTRY AND BIOPHYSICS, 2022, 80 (04) :737-745

[49] Myeloid-Specific Disruption of Tyrosine Phosphatase Shp2 Promotes Alternative Activation of Macrophages and Predisposes Mice to Pulmonary Fibrosis [J].

Tao, Bo ;

Jin, Wei ;

Xu, Jiaqi ;

Liang, Zuyu ;

Yao, Junlin ;

Zhang, Yun ;

Wang, Kai ;

Cheng, Hongqiang ;

Zhang, Xue ;

Ke, Yuehai .

JOURNAL OF IMMUNOLOGY, 2014, 193 (06) :2801-2811

[50] Secretoglobin 3A2 Suppresses Bleomycin-induced Pulmonary Fibrosis by Transforming Growth Factor β Signaling Down-regulation [J].

Kurotani, Reiko ;

Okumura, Satoshi ;

Matsubara, Tsutomu ;

Yokoyama, Utako ;

Buckley, John R. ;

Tomita, Takeshi ;

Kezuka, Kyohei ;

Nagano, Tomokazu ;

Esposito, Dominic ;

Taylor, Troy E. ;

Gillette, William K. ;

Ishikawa, Yoshihiro ;

Abe, Hiroyuki ;

Ward, Jerrold M. ;

Kimura, Shioko .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (22) :19682-19692

← 1 2 3 4 5 →